Moderna Inc. is developing a single vaccine that combines a booster dose against Covid-19 with the company’s experimental flu shot.

Vaccine developer Novavax Inc. said on Sept. 8 the company initiated an early-stage study to test a combination of the flu shot NanoFlu and the Covid-19 vaccine NVX-CoV2373.

Novavax Inc. said vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with the company’s Covid-19 vaccine candidate compared to those receiving its Covid-19 vaccine alone.

Novavax Inc. said on May 10 the company’s combined flu and Covid-19 vaccine produced functional antibodies against influenza and the coronavirus in a preclinical study.

A recent study published in Science Translational Medicine shows that a new flu vaccine appears to protect monkeys against influenza strains that are likely to cause a global pandemic, giving researchers hope that this vaccine could hold the key to providing a future universal flu vaccine for humans.

GlaxoSmithKline and Sanofi started a new clinical trial of their protein-based Covid-19 vaccine candidate, reviving their efforts against the pandemic after a setback in December delayed the shot’s launch.

A Covid-19 vaccine being developed by British American Tobacco from tobacco leaves was approved for human trials by the U.S. health regulator, the maker of Dunhill and Lucky Strike cigarettes said.

Genentech’s influenza treatment Xofluza (baloxavir marboxil) was granted approval by the U.S. Food and Drug Administration for use in people 12 years and older, making it the first single-dose post-exposure prophylaxis strategy approved by the regulatory agency.

For the first time ever, Klick Health took its in-office flu shot clinic on the road in keeping with the company’s people-first culture and commitment to help keep team members and their families healthy and happy.

Healthcare providers – including CVS Health Corp. – are kicking off flu vaccinations early, ordering extra shots and aiming to add tests that check for both the annual flu and COVID-19, pharmacy executives and experts told Reuters.